Gate2Brain
  • Home
  • Company
  • Team
  • Technology
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

How to transport drugs to the brain to treat pathologies?

News
¿Cómo transportar fármacos al cerebro para tratar patologías?La Vanguardia

El cerebro está protegido por la barrera hematoencefálica, que impide la entrada de bacterias, virus y otras sustancias nocivas. Pese a su función de resguardar el encéfalo, esta barrera se convierte en un obstáculo para los fármacos que deben alcanzar el órgano. Esto supone un reto a la hora de tratar enfermedades cerebrales, como los trastornos neurodegenerativos y psiquiátricos.

La spin-off Gate2Brain trabaja para desarrollar una nueva manera de superar esta barrera. “Diseñamos tractores moleculares que llevan el fármaco hasta donde no sabe llegar”, resume Meritxell Teixidó, consejera delegada y directora científica de la compañía. Su equipo investiga en unos péptidos lanzadera, proteínas muy pequeñas que, a través del torrente sanguíneo, son capaces de transportar hasta el cerebro un fármaco para tratar un tipo de cáncer cerebral infantil muy poco común, que hoy no cuenta con ningún tratamiento. En muchas ocasiones, como en esta, los fármacos existen, pero no hay manera de hacerlos llegar al cerebro.

El objetivo actual de esta spin-off , surgida desde el Institut de Recerca Biomèdica de Barcelona (IRB), la Universitat de Barcelona y el Institut de Recerca Sant Joan de Déu, es la validación preclínica del fármaco G2B-002 para demostrar que esta tecnología sirve para el tratamiento de enfermedades, como los tumores pediátricos poco frecuentes. Los ensayos clínicos en humanos no comenzarán antes del 2024. Según Teixidó, estos péptidos transportadores de fármacos podrán ser útiles para tratar otras patologías cerebrales, ya que sus “tractores” podrían convertirse en el vehículo de una amplia variedad de moléculas.

¿Cómo transportar fármacos al cerebro para tratar patologías?

Fuente: https://www.lavanguardia.com/vivo/lifestyle/20220117/7976694/suerte-cambio-psicologia-autoestima-nbs.html

 

January 17, 2022/by noticias
Tags: Gate2Brain, lavanguardia, tumores pediátricos
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/01/Captura-de-pantalla-2022-01-17-a-las-17.41.07.png 1544 2114 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-01-17 17:44:182022-01-17 17:51:00How to transport drugs to the brain to treat pathologies?
You might also like
Gate2Brain abre una ronda puenteo de un millón de euros para ensayos preclínicoPlantaDoce Gate2Brain opens one million euro bridge round for preclinical trials
Foment shows how the leadership of a new generation of female innovators is already a reality at # MWC21Foment del Treball Foment shows how the leadership of a new generation of female innovators is already a reality at # MWC21
‘Tractor’ proteins that carry drugs to the brain as therapy for incurable pediatric cancer
GATE2BRAIN winner of the Barcelona Activa Pre-acceleration competitionBarcelona Activa GATE2BRAIN WINNER OF THE BARCELONA ACTIVA PRE-ACCELERATION COMPETITION
Within the framework of the discussion-based interview series, Exploration Science, in which scientists talk about their ventures and areas of expertise, our CEO, Dr. Meritxell Teixidó, and the first and only APS American Peptide Idol joined @CEM's Dr. Wendy Hartsock to discuss the work @Gate2Brain is doing in pediatric oncology, dive into the technology, and talk about empathetic leadership and the power of diversity.CEM Exploration Science with Dr. Wendy Harsock
Una tecnología para ayudar a tratar el cáncer infantilgate2brain A technology to help treat pediatric cancer

CATEGORIES

  • Events
  • News
  • Podcast
  • Press releases
  • Publications
  • Videos

Events

  • Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.Gate2Brain will be attending The Investment Readiness SeriesApril 26, 2022 - 17:29
  • Gate2Brain is delighted to be attending next week's #AseBioInvestorDay2022, organised by Asociación Española de Bioempresas in Madrid.Gate2BrainGate2Brain attending Asebio Investor Day 2022April 21, 2022 - 14:46
  • 4YFN4YFNGATE2BRAIN will be participating in 4YFN at the Mobile World CongressFebruary 24, 2022 - 13:05
  • Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.TransfiereGate2Brain in Transfiere – European Forum for Science, Technology & InnovationFebruary 14, 2022 - 18:48
  • Innovatia 8.31st Innovatia 8.3 Investment ForumOctober 20, 2021 - 07:03

SOCIAL

  • linkedin
  • youtube

RSS RSS Ciencia

  • Catalonia participates in over 1,200 active clinical trials May 17, 2022 biocat
  • Startups from the BioRegion take part in TIRS Switzerland Edition to approach to Swiss ecosystem May 12, 2022 biocat
  • Barcelona to host BIOSPAIN 2023 May 12, 2022 biocat
  • HIGHLIGHTS: Improved working conditions for research staff, new investments by foreign companies and more sources of public funding April 28, 2022 biocat
  • Digitalizing clinical trials in Catalonia: lessons for the revolution April 25, 2022 biocat
  • Call now open for participants in “CRAASH Barcelona 2022” program April 19, 2022 biocat
  • HIGHLIGHTS: new rounds of investment, more funding in research, vaccines and innovation projects March 31, 2022 biocat
  • These are the seven startups taking part in the 30th Barcelona Healthcare Investment Forum March 28, 2022 biocat
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
G2B receives funding to accelerate its transfer to the market and society Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.Transfiere Gate2Brain in Transfiere – European Forum for Science, Technology &...
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}